These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 36411742)

  • 1. The value of a two-armed Bayesian response adaptive randomization trial.
    Gajewski BJ; Carlson SE; Brown AR; Mudaranthakam DP; Kerling EH; Valentine CJ
    J Biopharm Stat; 2023 Jan; 33(1):43-52. PubMed ID: 36411742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simulation study for evaluating the performance of response-adaptive randomization.
    Du Y; Wang X; Jack Lee J
    Contemp Clin Trials; 2015 Jan; 40():15-25. PubMed ID: 25460340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alternative models and randomization techniques for Bayesian response-adaptive randomization with binary outcomes.
    Proper J; Connett J; Murray T
    Clin Trials; 2021 Aug; 18(4):417-426. PubMed ID: 33926267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DHA supplementation for early preterm birth prevention: An application of Bayesian finite mixture models to adaptive clinical trial design optimization.
    Shi X; Wick JA; Christifano DN; Carlson SE; Brown AR; Mudaranthakam DP; Gajewski BJ
    Contemp Clin Trials; 2024 Jul; 144():107633. PubMed ID: 39013543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bayesian response adaptive randomization design with a composite endpoint of mortality and morbidity.
    Xu Z; Ma T; Tang L; Talisa VB; Chang CH
    Stat Med; 2024 Mar; 43(6):1256-1270. PubMed ID: 38258898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Doubly adaptive biased coin design to improve Bayesian clinical trials with time-to-event endpoints.
    Cao W; Zhu H; Wang L; Zhang L; Yu J
    Stat Med; 2024 Apr; 43(9):1743-1758. PubMed ID: 38387866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bayesian dose selection design for a binary outcome using restricted response adaptive randomization.
    Meinzer C; Martin R; Suarez JI
    Trials; 2017 Sep; 18(1):420. PubMed ID: 28886745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimizing a Bayesian hierarchical adaptive platform trial design for stroke patients.
    Gao G; Gajewski BJ; Wick J; Beall J; Saver JL; Meinzer C;
    Trials; 2022 Sep; 23(1):754. PubMed ID: 36068547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bayesian response adaptive randomization using longitudinal outcomes.
    Hatayama T; Morita S; Sakamaki K
    Pharm Stat; 2015; 14(5):369-76. PubMed ID: 26099995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resist the Temptation of Response-Adaptive Randomization.
    Proschan M; Evans S
    Clin Infect Dis; 2020 Dec; 71(11):3002-3004. PubMed ID: 32222766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implementation of statistical features of a Bayesian two-armed responsive adaptive randomization trial with post hoc analysis of time trend drift.
    Shergina E; Richter KP; Zhang C; Mussulman L; Nazir N; Gajewski BJ
    J Biopharm Stat; 2024 Jun; ():1-15. PubMed ID: 38847351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statistical inference for response adaptive randomization procedures with adjusted optimal allocation proportions.
    Zhu H
    J Biopharm Stat; 2017; 27(5):732-740. PubMed ID: 27937121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Bayesian sequential design with adaptive randomization for 2-sided hypothesis test.
    Yu Q; Zhu L; Zhu H
    Pharm Stat; 2017 Nov; 16(6):451-465. PubMed ID: 28980435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of clinical development pathways to advance tuberculosis regimen development.
    Chang V; Phillips PPJ; Imperial MZ; Nahid P; Savic RM
    BMC Infect Dis; 2022 Dec; 22(1):920. PubMed ID: 36494644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bayesian adaptive clinical trial designs for respiratory medicine.
    Ryan EG; Couturier DL; Heritier S
    Respirology; 2022 Oct; 27(10):834-843. PubMed ID: 35918280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The UPMC OPTIMISE-C19 (OPtimizing Treatment and Impact of Monoclonal antIbodieS through Evaluation for COVID-19) trial: a structured summary of a study protocol for an open-label, pragmatic, comparative effectiveness platform trial with response-adaptive randomization.
    Huang DT; McCreary EK; Bariola JR; Wadas RJ; Kip KE; Marroquin OC; Koscumb S; Collins K; Shovel JA; Schmidhofer M; Wisniewski MK; Sullivan C; Yealy DM; Axe M; Nace DA; Haidar G; Khadem T; Linstrum K; Snyder GM; Seymour CW; Montgomery SK; McVerry BJ; Berry L; Berry S; Meyers R; Weissman A; Peck-Palmer OM; Wells A; Bart R; Albin DL; Minnier T; Angus DC
    Trials; 2021 May; 22(1):363. PubMed ID: 34034784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of structural racism, pandemic stress, and SARS-CoV-2 infection during pregnancy with adverse birth outcomes.
    Janevic T; Lieb W; Ibroci E; Lynch J; Lieber M; Molenaar NM; Rommel AS; de Witte L; Ohrn S; Carreño JM; Krammer F; Zapata LB; Snead MC; Brody RI; Jessel RH; Sestito S; Adler A; Afzal O; Gigase F; Missall R; Carrión D; Stone J; Bergink V; Dolan SM; Howell EA;
    Am J Obstet Gynecol MFM; 2022 Jul; 4(4):100649. PubMed ID: 35462058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of DHA on reducing early preterm birth: the ADORE randomized controlled trial protocol.
    Carlson SE; Gajewski BJ; Valentine CJ; Rogers LK; Weiner CP; DeFranco EA; Buhimschi CS
    BMC Pregnancy Childbirth; 2017 Feb; 17(1):62. PubMed ID: 28193189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.